A detailed history of Bi Asset Management Fondsmaeglerselskab A transactions in Exact Sciences Corp stock. As of the latest transaction made, Bi Asset Management Fondsmaeglerselskab A holds 2,660 shares of EXAS stock, worth $131,217. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,660
Holding current value
$131,217
% of portfolio
0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$42.43 - $70.83 $112,863 - $188,407
2,660 New
2,660 $181,000
Q1 2024

May 03, 2024

SELL
$56.27 - $73.77 $13,392 - $17,557
-238 Reduced 4.17%
5,475 $378,000
Q4 2023

Feb 09, 2024

SELL
$59.06 - $75.72 $2.16 Million - $2.77 Million
-36,605 Reduced 86.5%
5,713 $423,000
Q3 2023

Nov 13, 2023

BUY
$65.94 - $99.04 $2.31 Million - $3.48 Million
35,093 Added 485.72%
42,318 $2.89 Million
Q2 2023

Aug 03, 2023

BUY
$62.68 - $95.05 $290,396 - $440,366
4,633 Added 178.74%
7,225 $678,000
Q1 2023

May 12, 2023

BUY
$47.19 - $70.77 $12,977 - $19,461
275 Added 11.87%
2,592 $176,000
Q4 2022

Feb 13, 2023

BUY
$30.35 - $53.15 $70,320 - $123,148
2,317 New
2,317 $115,000
Q4 2020

Feb 12, 2021

SELL
$99.61 - $142.12 $27,392 - $39,083
-275 Closed
0 $0
Q3 2020

Nov 09, 2020

BUY
$72.92 - $102.01 $20,053 - $28,052
275 New
275 $28,000
Q4 2019

Mar 19, 2020

SELL
$77.66 - $99.74 $982,554 - $1.26 Million
-12,652 Closed
0 $0
Q3 2019

Mar 19, 2020

BUY
$90.37 - $122.49 $1.14 Million - $1.55 Million
12,652 New
12,652 $1.14 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $8.73B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Bi Asset Management Fondsmaeglerselskab A Portfolio

Follow Bi Asset Management Fondsmaeglerselskab A and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bi Asset Management Fondsmaeglerselskab A, based on Form 13F filings with the SEC.

News

Stay updated on Bi Asset Management Fondsmaeglerselskab A with notifications on news.